Organigram Holdings Inc

NASDAQ: OGI
$2.32
-$0.02 (-0.9%)
Closing price October 25, 2021
Pot grower Tilray is acquiring a majority position in U.S.-based cannabis retailer MedMen. Is this a portent of more consolidation in the industry?
Wednesday's announcement of a draft bill that would decriminalize marijuana sent cannabis stocks plummeting. At least some analysts, however, continue to believe in the sector.
Wednesday's top analyst upgrades and downgrades included AutoZone, Citrix Systems, Coinbase, CSX, Freeport-McMoRan, Intuitive Surgical, Morgan Stanley, Netflix and Oracle.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including NovoCure, Synchrony, Twitter and Yum! Brands.
With major earnings reports for the March quarter due to begin next week, we end the current earnings season with quarterly reports for a nuts and bolts company and a marijuana producer.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Carvana, DocuSign, F5 Networks and OrganiGram.
Large marijuana stocks have risen sharply since the U.S. elections early in November. The increase is not based so much on the results as on what could happen next.
Wednesday's top analyst upgrades and downgrades included Delta Air Lines, Hasbro, Illumina, Lululemon Athletica, Micron Technologies, Nike, Penn National, Shopify, Southwest Airlines, Starbucks and...
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in fiscal...
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.